UniProt ID | CO4B_HUMAN | |
---|---|---|
UniProt AC | P0C0L5 | |
Protein Name | Complement C4-B | |
Gene Name | C4B | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1744 | |
Subcellular Localization | Secreted. Cell junction, synapse . Cell projection, axon . Cell projection, dendrite . | |
Protein Description | Non-enzymatic component of the C3 and C5 convertases and thus essential for the propagation of the classical complement pathway. Covalently binds to immunoglobulins and immune complexes and enhances the solubilization of immune aggregates and the clearance of IC through CR1 on erythrocytes. C4A isotype is responsible for effective binding to form amide bonds with immune aggregates or protein antigens, while C4B isotype catalyzes the transacylation of the thioester carbonyl group to form ester bonds with carbohydrate antigens.; Derived from proteolytic degradation of complement C4, C4a anaphylatoxin is a mediator of local inflammatory process. It induces the contraction of smooth muscle, increases vascular permeability and causes histamine release from mast cells and basophilic leukocytes.. | |
Protein Sequence | MRLLWGLIWASSFFTLSLQKPRLLLFSPSVVHLGVPLSVGVQLQDVPRGQVVKGSVFLRNPSRNNVPCSPKVDFTLSSERDFALLSLQVPLKDAKSCGLHQLLRGPEVQLVAHSPWLKDSLSRTTNIQGINLLFSSRRGHLFLQTDQPIYNPGQRVRYRVFALDQKMRPSTDTITVMVENSHGLRVRKKEVYMPSSIFQDDFVIPDISEPGTWKISARFSDGLESNSSTQFEVKKYVLPNFEVKITPGKPYILTVPGHLDEMQLDIQARYIYGKPVQGVAYVRFGLLDEDGKKTFFRGLESQTKLVNGQSHISLSKAEFQDALEKLNMGITDLQGLRLYVAAAIIESPGGEMEEAELTSWYFVSSPFSLDLSKTKRHLVPGAPFLLQALVREMSGSPASGIPVKVSATVSSPGSVPEVQDIQQNTDGSGQVSIPIIIPQTISELQLSVSAGSPHPAIARLTVAAPPSGGPGFLSIERPDSRPPRVGDTLNLNLRAVGSGATFSHYYYMILSRGQIVFMNREPKRTLTSVSVFVDHHLAPSFYFVAFYYHGDHPVANSLRVDVQAGACEGKLELSVDGAKQYRNGESVKLHLETDSLALVALGALDTALYAAGSKSHKPLNMGKVFEAMNSYDLGCGPGGGDSALQVFQAAGLAFSDGDQWTLSRKRLSCPKEKTTRKKRNVNFQKAINEKLGQYASPTAKRCCQDGVTRLPMMRSCEQRAARVQQPDCREPFLSCCQFAESLRKKSRDKGQAGLQRALEILQEEDLIDEDDIPVRSFFPENWLWRVETVDRFQILTLWLPDSLTTWEIHGLSLSKTKGLCVATPVQLRVFREFHLHLRLPMSVRRFEQLELRPVLYNYLDKNLTVSVHVSPVEGLCLAGGGGLAQQVLVPAGSARPVAFSVVPTAATAVSLKVVARGSFEFPVGDAVSKVLQIEKEGAIHREELVYELNPLDHRGRTLEIPGNSDPNMIPDGDFNSYVRVTASDPLDTLGSEGALSPGGVASLLRLPRGCGEQTMIYLAPTLAASRYLDKTEQWSTLPPETKDHAVDLIQKGYMRIQQFRKADGSYAAWLSRGSSTWLTAFVLKVLSLAQEQVGGSPEKLQETSNWLLSQQQADGSFQDLSPVIHRSMQGGLVGNDETVALTAFVTIALHHGLAVFQDEGAEPLKQRVEASISKASSFLGEKASAGLLGAHAAAITAYALTLTKAPADLRGVAHNNLMAMAQETGDNLYWGSVTGSQSNAVSPTPAPRNPSDPMPQAPALWIETTAYALLHLLLHEGKAEMADQAAAWLTRQGSFQGGFRSTQDTVIALDALSAYWIASHTTEERGLNVTLSSTGRNGFKSHALQLNNRQIRGLEEELQFSLGSKINVKVGGNSKGTLKVLRTYNVLDMKNTTCQDLQIEVTVKGHVEYTMEANEDYEDYEYDELPAKDDPDAPLQPVTPLQLFEGRRNRRRREAPKVVEEQESRVHYTVCIWRNGKVGLSGMAIADVTLLSGFHALRADLEKLTSLSDRYVSHFETEGPHVLLYFDSVPTSRECVGFEAVQEVPVGLVQPASATLYDYYNPERRCSVFYGAPSKSRLLATLCSAEVCQCAEGKCPRQRRALERGLQDEDGYRMKFACYYPRVEYGFQVKVLREDSRAAFRLFETKITQVLHFTKDVKAAANQMRNFLVRASCRLRLEPGKEYLIMGLDGATYDLEGHPQYLLDSNSWIEEMPSERLCRSTRQRAACAQLNDFLQEYGTQGCQV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
17 | Phosphorylation | ASSFFTLSLQKPRLL HHHHHHHCCCCCEEE | 26.20 | 24719451 | |
77 | Phosphorylation | PKVDFTLSSERDFAL CCEEEEECCCCCEEE | 27.39 | 24275569 | |
125 | Phosphorylation | KDSLSRTTNIQGINL HHHHCCCCCCCCCEE | 29.25 | 30087585 | |
158 | Phosphorylation | NPGQRVRYRVFALDQ CCCCCEEEEEEEECC | 14.31 | 28258704 | |
171 | Phosphorylation | DQKMRPSTDTITVMV CCCCCCCCCEEEEEE | 39.58 | 28258704 | |
173 | Phosphorylation | KMRPSTDTITVMVEN CCCCCCCEEEEEEEC | 20.73 | 28258704 | |
226 | N-linked_Glycosylation | FSDGLESNSSTQFEV ECCCCCCCCCCCEEE | 30.51 | 12754519 | |
236 | Phosphorylation | TQFEVKKYVLPNFEV CCEEEEEEECCCEEE | 11.08 | 22461510 | |
310 | O-linked_Glycosylation | TKLVNGQSHISLSKA CEEECCCCCEECCHH | 24.96 | 31492838 | |
313 | Phosphorylation | VNGQSHISLSKAEFQ ECCCCCEECCHHHHH | 22.59 | 24719451 | |
313 | O-linked_Glycosylation | VNGQSHISLSKAEFQ ECCCCCEECCHHHHH | 22.59 | 31492838 | |
678 | Acetylation | KEKTTRKKRNVNFQK CCCCCCHHCCCCHHH | 46.01 | 30587339 | |
696 | O-linked_Glycosylation | EKLGQYASPTAKRCC HHHHCCCCHHHHHHC | 20.18 | OGP | |
696 | Phosphorylation | EKLGQYASPTAKRCC HHHHCCCCHHHHHHC | 20.18 | 23532336 | |
698 | O-linked_Glycosylation | LGQYASPTAKRCCQD HHCCCCHHHHHHCCC | 42.17 | OGP | |
812 | Phosphorylation | TWEIHGLSLSKTKGL CEEEECEECCCCCCE | 34.88 | 24719451 | |
856 | Phosphorylation | LELRPVLYNYLDKNL HCCHHHHHHHHCCCC | 11.29 | 26074081 | |
858 | Phosphorylation | LRPVLYNYLDKNLTV CHHHHHHHHCCCCEE | 11.61 | 26074081 | |
862 | N-linked_Glycosylation | LYNYLDKNLTVSVHV HHHHHCCCCEEEEEE | 40.38 | UniProtKB CARBOHYD | |
864 | Phosphorylation | NYLDKNLTVSVHVSP HHHCCCCEEEEEECC | 21.82 | 26074081 | |
866 | Phosphorylation | LDKNLTVSVHVSPVE HCCCCEEEEEECCCC | 10.98 | 26074081 | |
870 | Phosphorylation | LTVSVHVSPVEGLCL CEEEEEECCCCCEEE | 14.35 | 26074081 | |
918 | Phosphorylation | LKVVARGSFEFPVGD EEEEECCCEEEECCH | 18.95 | 24505115 | |
964 | Phosphorylation | TLEIPGNSDPNMIPD EEECCCCCCCCCCCC | 61.43 | 24505115 | |
988 | Phosphorylation | TASDPLDTLGSEGAL EECCCCCCCCCCCCC | 40.47 | 23612710 | |
991 | Phosphorylation | DPLDTLGSEGALSPG CCCCCCCCCCCCCCC | 35.65 | 23612710 | |
1014 | Phosphorylation | PRGCGEQTMIYLAPT CCCCCCCHHHHHHCH | 10.96 | 24505115 | |
1109 | Phosphorylation | ETSNWLLSQQQADGS HHHHHHHHHHHCCCC | 24.63 | 19562805 | |
1176 | Phosphorylation | EASISKASSFLGEKA HHHHHHHHHHHCCHH | 36.71 | 29449344 | |
1177 | Phosphorylation | ASISKASSFLGEKAS HHHHHHHHHHCCHHH | 27.06 | 29449344 | |
1196 | Phosphorylation | GAHAAAITAYALTLT HHHHHHHHHHHHHHC | 14.64 | 22496350 | |
1242 | O-linked_Glycosylation | GSQSNAVSPTPAPRN CCCCCCCCCCCCCCC | 22.20 | OGP | |
1244 | O-linked_Glycosylation | QSNAVSPTPAPRNPS CCCCCCCCCCCCCCC | 25.28 | OGP | |
1251 | O-linked_Glycosylation | TPAPRNPSDPMPQAP CCCCCCCCCCCCCCC | 58.87 | OGP | |
1328 | N-linked_Glycosylation | TTEERGLNVTLSSTG CCCCCCCEEEEECCC | 27.79 | 16740002 | |
1330 | Phosphorylation | EERGLNVTLSSTGRN CCCCCEEEEECCCCC | 21.61 | 24719451 | |
1332 | Phosphorylation | RGLNVTLSSTGRNGF CCCEEEEECCCCCCH | 19.25 | 24719451 | |
1334 | Phosphorylation | LNVTLSSTGRNGFKS CEEEEECCCCCCHHH | 36.46 | 24719451 | |
1341 | Phosphorylation | TGRNGFKSHALQLNN CCCCCHHHHEEEECH | 16.25 | 19664994 | |
1374 | Phosphorylation | NVKVGGNSKGTLKVL EEEECCCCCCCEEEE | 35.42 | - | |
1391 | N-linked_Glycosylation | YNVLDMKNTTCQDLQ EEEEECCCCCCCEEE | 33.70 | 14760718 | |
1417 | Sulfation | TMEANEDYEDYEYDE EEECCCCCCCCCCCC | 12.43 | - | |
1417 | Sulfation | TMEANEDYEDYEYDE EEECCCCCCCCCCCC | 12.43 | 3944109 | |
1420 | Sulfation | ANEDYEDYEYDELPA CCCCCCCCCCCCCCC | 12.40 | 3944109 | |
1420 | Sulfation | ANEDYEDYEYDELPA CCCCCCCCCCCCCCC | 12.40 | - | |
1422 | Sulfation | EDYEDYEYDELPAKD CCCCCCCCCCCCCCC | 14.42 | 3944109 | |
1422 | Sulfation | EDYEDYEYDELPAKD CCCCCCCCCCCCCCC | 14.42 | - | |
1505 | Phosphorylation | RADLEKLTSLSDRYV HHCHHHHHCCCHHHH | 38.39 | 23403867 | |
1506 | Phosphorylation | ADLEKLTSLSDRYVS HCHHHHHCCCHHHHH | 35.99 | 23403867 | |
1567 | Phosphorylation | YNPERRCSVFYGAPS CCCCCCEEEEECCCC | 17.28 | 28857561 | |
1584 | Phosphorylation | RLLATLCSAEVCQCA HHHHHHHHHHHHHHH | 30.49 | 24505115 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CO4B_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CO4B_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CO4B_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
152700 | Systemic lupus erythematosus (SLE) | |||||
614379 | Complement component 4B deficiency (C4BD) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Identification of N-linked glycoproteins in human saliva byglycoprotein capture and mass spectrometry."; Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong D.T.,Loo J.A.; J. Proteome Res. 5:1493-1503(2006). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1328, AND MASSSPECTROMETRY. | |
"Screening for N-glycosylated proteins by liquid chromatography massspectrometry."; Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.; Proteomics 4:454-465(2004). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1391, AND MASSSPECTROMETRY. | |
"Identification and quantification of N-linked glycoproteins usinghydrazide chemistry, stable isotope labeling and mass spectrometry."; Zhang H., Li X.-J., Martin D.B., Aebersold R.; Nat. Biotechnol. 21:660-666(2003). Cited for: GLYCOSYLATION AT ASN-226. |